bf/NASDAQ:BGNE_icon.jpeg

COM:BEIGENE

BeiGene

  • Stock

USD

Last Close

194.56

22/11 21:00

Market Cap

15.82B

Beta: -

Volume Today

222.26K

Avg: -

Company Overview

Metric
Company NameBeiGene, Ltd.Reliance Life SciencesSierra OncologyXynomic Pharmaceuticals Holdings, Inc.
SymbolBGNE
MSH IDCOM:BEIGENECOM:RELLIFECOM:SIERRAONCOLOGYCOM:XYNOMICPHARMA
MarketSTOCKSPRIVATEPRIVATEPRIVATE
SectorHealthcareHealthcare & Health ServicesHealthcare & Health ServicesHealthcare & Health Services
IndustryBiotechnologyBiotechnologyPharmaceuticalsPharmaceuticals
CountryUSINGBUS
StageSeries B
Employee Count10K
Websitebeigene.comrellife.comsierraoncology.comxynomicpharma.com
LinkedIn
Founders

Market Metrics

Metric
Market Cap15.82B
Enterprise Value
Monthly Web Traffic17.18K1.52K
Web Traffic Growth0.084.19
Valuation
Raised Capital

Financial Performance

Metric
Revenue2.46B
Revenue (LTM)
Revenue (NTM)
Gross Profit1.99B
EBITDA-1.12B
Operating Income-1.21B
Net Income-881.71M
EPS-8.45
Diluted EPS-8.45
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Growth Metrics

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Profitability Ratios

Metric
Gross Profit Margin0.84
Operating Profit Margin-0.29
EBITDA Margin-0.46
Net Profit Margin-0.17
Return on Equity-0.15
Return on Assets-0.09
Return on Capital Employed-0.23

Valuation Multiples

Metric
P/E Ratio-20.11
P/B Ratio5.13
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio8.97
EV Multiple-16.29

Operational Metrics

Metric
Days Sales Outstanding58.72
Days Payables Outstanding102.58
Days Inventory Outstanding331.60
Operating Cycle394.01
Cash Conversion Cycle147.98
Asset Turnover0.54

Cash Flow Metrics

Metric
Operating Cash Flow-1.16B
Free Cash Flow-1.74B
Cash Flow to Debt-0.56
Operating Cash Flow/Sales-0.20
Free Cash Flow Yield-0.13

Balance Sheet Metrics

Metric
Cash & Equivalents3.18B
Accounts Receivable-188.31M
Inventory416.12M
Goodwill
Debt to Capitalization0.24
Debt to Assets0.10
Current Ratio3.16
Quick Ratio1.98

Efficiency Metrics

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue0.16
R&D to Revenue1.16
SG&A to Revenue